Imagine tiny fists punching their way through your body. For some cancer patients, this may be the reality. Melanoma cells…
Read More »Cancer
Longtime U.S. Rep. Sheila Jackson Lee of Texas, who helped lead federal efforts to protect women from domestic violence and…
Read More »The recent U.S. Food and Drug Administration approval of lifileucel, the first commercial tumor-infiltrating lymphocyte (TIL) therapy for advanced melanoma,…
Read More »JHVEPhoto/iStock Editorial via Getty Images McKesson (NYSE:MCK), Cardinal Health (NYSE:CAH), and Cencora (NYSE:COR) are said to be interested in acquiring…
Read More »In early 2023, Maria Menounos suspected something was going on with her health. She’d been dealing with unexplained bloating for…
Read More »Collaboration explores the potential synergistic effects of Checkpoint’s anti-PD-L1, cosibelimab, in combination with the autologous T cell therapy, Immuncell-LC YONGIN,…
Read More »Sen. Amy Klobuchar (D-Minn.) on Friday said she is cancer free after undergoing a minimally-invasive procedure to remove a small…
Read More »Researchers at University of California San Diego have found that the most common form of liver cancer — one with…
Read More »Stay informed with free updates Simply sign up to the War in Ukraine myFT Digest — delivered directly to your…
Read More »Cancer is insidious. Throughout tumor progression, the disease hijacks otherwise healthy biological processes — like the body’s immune response —…
Read More »